Hair loss treatments have been stuck in a rut for decades. Minoxidil (Rogaine) and finasteride (Propecia) remain the only two FDA-approved pharmaceutical options, and both come with significant limitations. A new class of peptide-based treatments is emerging that offers a different approach — one rooted in the same biology of cellular signaling that has already transformed skincare.
GHK-Cu: The Multi-Talent
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring tripeptide that binds copper ions. Originally studied for wound healing and collagen remodeling, GHK-Cu has gained attention for hair restoration after research showed it could enlarge hair follicles and stimulate growth.
A key study by Pickart et al. found that GHK-Cu increased follicle size by 29% compared to controls, outperforming minoxidil 5% in the same trial. The peptide appears to work through multiple mechanisms: stimulating blood vessel formation around follicles, promoting dermal papilla cell proliferation, and modulating the Wnt/beta-catenin signaling pathway that controls the hair growth cycle.
How Hair Growth Cycles Work
Hair follicles cycle through three phases: anagen (active growth, 2–7 years), catagen (regression, 2–3 weeks), and telogen (rest, 3 months). In pattern hair loss, the anagen phase progressively shortens while telogen lengthens, producing thinner, shorter hairs until the follicle eventually miniaturizes.
Peptide-based treatments aim to extend the anagen phase and reactivate follicles that have entered prolonged telogen. This is a fundamentally different approach than finasteride (which blocks DHT systemically) or minoxidil (which works primarily through vasodilation).
Biomimetic Peptides for Hair
Acetyl Tetrapeptide-3 is a signal peptide that targets the dermal papilla — the cluster of cells at the base of the follicle that controls hair growth. Research suggests it anchors existing hair more firmly and reduces the inflammatory signaling that contributes to follicle miniaturization.
Biotinoyl Tripeptide-1 combines a biotin derivative with a peptide sequence that improves metabolic activity in hair matrix cells. Clinical studies show improvements in hair density, strength, and resistance to breakage.
These two peptides are often combined in the commercial ingredient Capixyl, which also includes red clover extract (a natural DHT inhibitor). A manufacturer-sponsored study found that Capixyl reduced hair loss by 46% and increased hair growth by 13% over four months.
Practical Application
For topical GHK-Cu, look for concentrations of 1–2% in scalp serums. Apply to clean, slightly damp scalp in the evening, focusing on thinning areas. Most studies show results after 3–6 months of consistent use.
For Capixyl-based products, The Ordinary's Multi-Peptide Serum for Hair Density is one of the most accessible options. Apply daily to the scalp, massage gently, and don't expect overnight results.
Sources
- Pickart L, et al. "GHK peptide as a natural modulator of multiple cellular pathways in skin biology." BioMed Research International, 2015. PubMed: 26236730
- Pyo HK, et al. "The effect of tripeptide-copper complex on human hair growth in vitro." Archives of Pharmacal Research, 30(7), 834–839 (2007). PubMed: 17703736
Ready to Start Your Peptide Journey?
Finding a qualified provider is the most important first step. Gatlan connects you with licensed telehealth professionals who specialize in peptide therapy — so you can get expert guidance, proper protocols, and pharmaceutical-grade peptides prescribed safely.
Use our Peptide Tracker to log your daily doses, track your protocols, and monitor your progress over time.